Boceprevir and telaprevir utilization evaluation for the treatment of chronic hepatitis C

• Autores principales: P. Marrero-Álvarez (Autor), I. Gil-Gómez (Autor), E. Monte-Boquet (Autor), L. Lorente-Fernández (Autor), J. L. Poveda-Andrés (Autor)
• Formato: Libro
• Publicado: Elsevier, 2014-01-01T00:00:00Z.
• Materias: article
• Acceso en línea: Connect to this object online.

Abstract: Introduction: Protease inhibitors, boceprevir and telaprevir, have changed the treatment paradigm of chronic hepatitis C (CHC). The objective is analyzing the degree of compliance with the recommendations for boceprevir and telaprevir use that have been issued for the Spanish Agency for Me...